Provided by Tiger Trade Technology Pte. Ltd.

BillionToOne, Inc.

98.09
+2.682.81%
Post-market: 98.090.00000.00%19:30 EDT
Volume:325.04K
Turnover:31.86M
Market Cap:4.63B
PE:127.55
High:100.31
Open:94.46
Low:94.46
Close:95.41
52wk High:150.44
52wk Low:61.96
Shares:47.19M
Float Shares:28.81M
Volume Ratio:0.54
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7690
EPS(LYR):0.1400
ROE:10.68%
ROA:5.19%
PB:8.62
PE(LYR):700.65

Loading ...

BillionToOne CTO David Tsao Disposes of 20,000 Common Shares for $2.11 Million

Reuters
·
Oct 08

BillionToOne Study Finds Northstar Response Tissue-Free ctDNA Assay Matches or Beats Tumor-Informed Monitoring in Advanced Cancer Patients

Reuters
·
Oct 07

BillionToOne is Maintained at Buy by Guggenheim

Dow Jones
·
Oct 01

BillionToOne Chairman and CEO Oguzhan Atay Disposes of USD 1,328,656 in Class a Common Shares

Reuters
·
Oct 01

BillionToOne SVP of Laboratory Operations John Roderick Ten Bosch Disposes of 1,416 Common Shares Worth $169,920

Reuters
·
Sep 29

Billiontoone, Inc. : Piper Sandler Raises Target Price to $140 from $108

THOMSON REUTERS
·
Sep 25

BillionToOne SVP Laboratory Operations John Roderick Ten Bosch Sells 1,416 Shares for $150,965.76

Reuters
·
Sep 24

BillionToOne General Counsel Thomas P. Lynch Disposes of 35,112 Common Shares Worth USD 3.87 Million

Reuters
·
Sep 22

BillionToOne Chairman and CEO Oguzhan Atay Disposes of USD 2,637,450 Class a Common Shares

Reuters
·
Sep 17

BillionToOne General Counsel Thomas P. Lynch Sells 19,962 Class a Shares for $1.99 Million

Reuters
·
Sep 11

BillionToOne Management to Join Wells Fargo Annual Healthcare Conference Fireside Chat

Reuters
·
Sep 03

Canaccord Genuity Initiates BillionToOne at Buy With $120 Price Target

MT Newswires Live
·
Sep 02

BillionToOne Launches New Liquid Biopsy Test to Help Identify Tissue of Origin

MT Newswires Live
·
Sep 01

BillionToOne announces the launch of Northstar Origin

TIPRANKS
·
Sep 01

BillionToOne SVP Laboratory Operations John Roderick Ten Bosch Sells 1,417 Class a Shares for $141,700

Reuters
·
Aug 28

BillionToOne announces publication of study on cfDNA fetal risk assessment

TIPRANKS
·
Aug 19

BillionToOne Study in General-Risk Pregnancies Shows 94.4% Sensitivity for Unity cfDNA Recessive-Condition Screen

Reuters
·
Aug 19

BillionToOne CTO David Tsao Disposes of 10,000 Common Shares Worth $928,600

Reuters
·
Aug 13

Billiontoone, Inc. : Piper Sandler Cuts Target Price to $108 from $120

THOMSON REUTERS
·
Aug 10

Does BillionToOne’s (BLLN) Profitability Turn and Reaffirmed 2026 Outlook Redefine Its Core Investment Story?

Simply Wall St.
·
Aug 09